Nigel Temperton Vial Pseudotype Unit, Medway School of Pharmacy, University of Kent, United Kingdom, United Kingdom,
2 protocols

Fabrizio Biuso 1 protocol

Eleonora Molesti 1 protocol
Jeremy Welsch University of Michigan, Medical School
3 protocols

Longping Tse University of North Carolina at Chapel Hill
27 protocols

Masfique Mehedi University of North Dakota
3 protocols

Ran Chen Zhejiang JFK Biological Technology Co. Ltd.
6 protocols

Reviewer
George William Carnell
  • Post-Doc, University of Cambridge
Research focus
  • Immunology
  • 2 Author merit

Education

PhD, University of Kent, 2018

2 Protocols published
慢病毒假型酶联凝集素分析测定针对流感神经氨酸酶的抗体
Authors:  Fabrizio Biuso, George Carnell, Emanuele Montomoli and Nigel Temperton, date: 07/20/2018, view: 4853, Q&A: 0
This protocol describes the rapid and safe production of lentiviral pseudotypes characterized by a lentiviral core containing a reporter, in conjunction with avian influenza haemagglutinin (HA) and human neuraminidase (NA) glycoproteins on the ...
利用PEI优化生产,滴定和中和SARS-CoV spike萤光素酶假病毒的方法
Authors:  George Carnell, Keith Grehan, Francesca Ferrara, Eleonora Molesti and Nigel Temperton, date: 08/20/2017, view: 12002, Q&A: 1
The protocol outlined represents a cost-effective, rapid and reliable method for the generation of high-titre viral pseudotype particles with the wild-type SARS-CoV spike protein on a lentiviral vector core using the widely available transfection ...
5 Protocols reviewed
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike

The use of recombinant lentivirus pseudotyped with the coronavirus Spike protein of SARS-CoV-2 would circumvent the requirement of biosafety-level 3 (BSL-3) containment facilities for the handling of SARS-CoV-2 viruses. Herein, we describe a fast

...
More >
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike

The use of recombinant lentivirus pseudotyped with the coronavirus Spike protein of SARS-CoV-2 would circumvent the requirement of biosafety-level 3 (BSL-3) containment facilities for the handling of SARS-CoV-2 viruses. Herein, we describe a fast

...
More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.